SEC-sourced researchBeta
RCUS
Arcus Biosciences, Inc.
Company comparison ↗
Data passport
- CIK
- 0001724521
- Exchange
- NYSE
- Business activity
- — · SIC 2834
- Financial inputs
- 5/6
- Filing date
- Sep 28, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 117,000,000.0000 | Feb 25, 2026 |
| December 2024 | 258,000,000.0000 | Feb 25, 2026 |
| December 2025 | 247,000,000.0000 | Feb 25, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 247,000,000.0000 | -353,000,000.0000 | -482,000,000.0000 | 1,139,000,000.0000 | — | Feb 25, 2026 |
| December 2024 | 258,000,000.0000 | -283,000,000.0000 | -170,000,000.0000 | 1,150,000,000.0000 | — | Feb 25, 2026 |
| December 2023 | 117,000,000.0000 | -307,000,000.0000 | -306,000,000.0000 | — | — | Feb 25, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $247M | December 2025 | Feb 25, 2026 | 10-K |
| Previous period revenueRevenues | $258M | December 2024 | Feb 25, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$353M | December 2025 | Feb 25, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$482M | December 2025 | Feb 25, 2026 | 10-K |
| Total assetsAssets | $1.14B | December 2025 | Feb 25, 2026 | 10-K |
| Total liabilities | — | — | — | — |